Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Davis

Showing results (431-440 of 1,315) with videos related to

Pageof 132
Sort By:
Research Communications in Chemical Pathology and Pharmacology|March 1, 1977
Influence of freezing and storage methods on concentrations of brain DOPA and 5 HTP after pretreatment with a decarboxylase inhibitorM C McNamara, A T Miller, J N Davis
Physical Review Letters|June 1, 2004
New nucleosynthesis constraint on the variation of GCraig J Copi, Adam N Davis, Lawrence M Krauss
European Journal of Pharmacology|September 30, 1983
Brain alpha 1-adrenergic receptors: suitability of [125I]heat as a radioligand for in vitro autoradiographyL S Jones, L L Gauger, J N Davis
Nature|December 4, 1975
Direct identification and characterisation of beta-adrenergic receptors in rat brainR W Alexander, J N Davis, R J Lefkowitz
The Journal of Clinical Investigation|July 15, 1997
Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responsesS N Davis, C Shavers, B Davis, et al.
The Journal of Biological Chemistry|August 10, 1977
alpha-Adrenergic receptors in rat parotid cells. I. Correlation of [3H]dihydroergocryptine binding and catecholamine-stimulated potassium effluxW J Strittmatter, J N Davis, R J Lefkowitz
The Journal of Biological Chemistry|August 10, 1977
alpha-Adrenergic receptors in rat parotid cells. II. Desensitization of receptor binding sites and potassium releaseW J Strittmatter, J N Davis, R J Lefkowitz
Molecular Medicine Today|August 1, 1995
A mitochondrial bottleneck hypothesis of Alzheimer's diseaseJ N Davis, E J Hunnicutt, J C Chisholm
Expert Opinion on Drug Metabolism & Toxicology|February 20, 2014
Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetesStephanie A Stein, Elizabeth M Lamos, Stephen N Davis
Pharmacology, Biochemistry, and Behavior|September 1, 1995
CRF administered to pregnant rats alters offspring behavior and morphologyM T Williams, M B Hennessy, H N Davis
Pageof 132

Showing results (431-440 of 1,315) with videos related to

Sort By:
Pageof 132
Research Communications in Chemical Pathology and Pharmacology|March 1, 1977
Influence of freezing and storage methods on concentrations of brain DOPA and 5 HTP after pretreatment with a decarboxylase inhibitorM C McNamara, A T Miller, J N Davis
Physical Review Letters|June 1, 2004
New nucleosynthesis constraint on the variation of GCraig J Copi, Adam N Davis, Lawrence M Krauss
European Journal of Pharmacology|September 30, 1983
Brain alpha 1-adrenergic receptors: suitability of [125I]heat as a radioligand for in vitro autoradiographyL S Jones, L L Gauger, J N Davis
Nature|December 4, 1975
Direct identification and characterisation of beta-adrenergic receptors in rat brainR W Alexander, J N Davis, R J Lefkowitz
The Journal of Clinical Investigation|July 15, 1997
Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responsesS N Davis, C Shavers, B Davis, et al.
The Journal of Biological Chemistry|August 10, 1977
alpha-Adrenergic receptors in rat parotid cells. I. Correlation of [3H]dihydroergocryptine binding and catecholamine-stimulated potassium effluxW J Strittmatter, J N Davis, R J Lefkowitz
The Journal of Biological Chemistry|August 10, 1977
alpha-Adrenergic receptors in rat parotid cells. II. Desensitization of receptor binding sites and potassium releaseW J Strittmatter, J N Davis, R J Lefkowitz
Molecular Medicine Today|August 1, 1995
A mitochondrial bottleneck hypothesis of Alzheimer's diseaseJ N Davis, E J Hunnicutt, J C Chisholm
Expert Opinion on Drug Metabolism & Toxicology|February 20, 2014
Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetesStephanie A Stein, Elizabeth M Lamos, Stephen N Davis
Pharmacology, Biochemistry, and Behavior|September 1, 1995
CRF administered to pregnant rats alters offspring behavior and morphologyM T Williams, M B Hennessy, H N Davis
Pageof 132